{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:57:12Z","timestamp":1782280632101,"version":"3.54.5"},"posted":{"date-parts":[[2025,9,2]]},"group-title":"Microbiology","reference-count":33,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,9,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>The human angiotensin-converting enzyme 2 (hACE2) is the primary receptor for the entry of SARS-CoV-2. Some human alleles of ACE2 exhibit an improved affinity for the SARS-CoV-2 Spike protein. However, the impact of ACE2 polymorphisms on SARS-CoV-2 infection remains unclear. Our previous study predicted that G431 and S514 in the receptor-binding domain (RBD) od SARS-CoV-2 S1 domain are important for S protein stability, and that S protein residues G496 and F497 and ACE2 residues D355 and Y41 are critical for the RBD\u2013ACE2 interaction (1). In this study, we explored the potential of hACE2-derived neutralizing peptides as a therapeutic strategy against SARS-CoV-2 and investigated how ACE2 polymorphisms affect RBD\u2013ACE2 binding affinity. We applied computational saturation mutagenesis to systematically screen the binding affinity changes among all possible ACE2 missense mutations within the ACE2\u2013Wuhan-S1 complex. Mutations at ACE2 residues D355 and Y41 were predicted to weaken binding affinity, whereas those at N330 and D30 enhanced it. We identified six ACE2 regions (19\u201349, 65\u2013102, 320\u2013333, 348\u2013359, 378\u2013395, 552\u2013563) to be vital for ACE2\u2013RBD interaction. We synthesized peptides corresponding to these six regions and tested them using a pseudotyped viral particle system and dot blot assay. Three peptides were confirmed to bind with S protein, and four exhibited inhibitory effects. We aligned ACE2\u2013Wuhan-S1 and ACE2\u2013Omicron-S1 complexes, conducted correlation analysis, and observed similar binding patterns, suggesting that these peptides also have potential to neutralize Omicron strains.<\/jats:p>\n                <jats:sec>\n                  <jats:title>IMPORTANCE<\/jats:title>\n                  <jats:p>SARS-CoV-2 continues its global spread. In this research, we identified six regions within ACE2 that are vital for interaction with the viral S RBD and have potential to neutralize SARS-CoV-2 infection. Among the six peptides derived from ACE2, three were confirmed to bind with S protein of Wuahan strain, and four exhibited inhibitory effects on Wuahn strain SARS-CoV-2. We also found ACE2 residues D355 and Y41 as weakening affinity, and N330 and D30 as enhancing it. We also aligned this complex with the ACE2\u2013Omicron-S1 complex, performed correlation analyses, and compared their patterns of stability changes upon mutations, and obtained similar results, indicating that these peptides may also be effective against Omicron variants. These results provide insight into the role of ACE2 polymorphism in viral entry and suggest that hACE2-derived peptides may offer a promising therapeutic strategy against SARS-CoV-2, demonstrating strong consistency between our computational predictions and experimental outcomes.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.09.01.673483","type":"posted-content","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:35:15Z","timestamp":1756874115000},"source":"Crossref","is-referenced-by-count":0,"title":["Computational and Experimental Identification of Potential Neutralizing Peptides Derived from Human ACE2 Against SARS-CoV-2 Infection"],"prefix":"10.64898","author":[{"given":"Qiaobin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhyanand","family":"Mahase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangheng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cruz-Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-2356","authenticated-orcid":false,"given":"Qiyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-9889","authenticated-orcid":false,"given":"Shaolei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025090607500459000_2025.09.01.673483v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa233"},{"key":"2025090607500459000_2025.09.01.673483v1.2","doi-asserted-by":"crossref","first-page":"152805","DOI":"10.1016\/j.semarthrit.2025.152805","article-title":"Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis","volume":"74","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2025090607500459000_2025.09.01.673483v1.3","doi-asserted-by":"crossref","first-page":"112417","DOI":"10.1016\/j.diabres.2025.112417","article-title":"New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis","volume":"227","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2025090607500459000_2025.09.01.673483v1.4","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1192\/bjo.2025.10801","article-title":"Changes in mental health of adolescents during three months of the COVID-19 pandemic: longitudinal study","volume":"11","year":"2025","journal-title":"BJPsych Open"},{"issue":"4","key":"2025090607500459000_2025.09.01.673483v1.5","first-page":"795","article-title":"Effects of the COVID-19 Pandemic on Anxiety and Depression among Medical Interns","volume":"26","year":"2025","journal-title":"West J Emerg Med"},{"key":"2025090607500459000_2025.09.01.673483v1.6","unstructured":"Organization WH. WHO coronavirus (COVID-19) dashboard 2025 [Available from: https:\/\/covid19.who.int\/."},{"key":"2025090607500459000_2025.09.01.673483v1.7","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-012-2811-1"},{"key":"2025090607500459000_2025.09.01.673483v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00418-x"},{"key":"2025090607500459000_2025.09.01.673483v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00630-8"},{"key":"2025090607500459000_2025.09.01.673483v1.10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.0c00664"},{"key":"2025090607500459000_2025.09.01.673483v1.11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785941"},{"issue":"1","key":"2025090607500459000_2025.09.01.673483v1.12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","article-title":"ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker","volume":"6","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025090607500459000_2025.09.01.673483v1.13","doi-asserted-by":"crossref","first-page":"3892370","DOI":"10.1155\/2023\/3892370","article-title":"Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern","volume":"2023","year":"2023","journal-title":"Biomed Res Int"},{"issue":"5-6","key":"2025090607500459000_2025.09.01.673483v1.14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1515\/hsz-2021-0426","article-title":"Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein","volume":"403","year":"2022","journal-title":"Biol Chem"},{"issue":"32","key":"2025090607500459000_2025.09.01.673483v1.15","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1021\/acs.jpclett.2c01155","article-title":"Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches","volume":"13","year":"2022","journal-title":"J Phys Chem Lett"},{"issue":"41","key":"2025090607500459000_2025.09.01.673483v1.16","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1021\/acs.jpcb.2c03918","article-title":"Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors","volume":"126","year":"2022","journal-title":"J Phys Chem B"},{"issue":"1","key":"2025090607500459000_2025.09.01.673483v1.17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s42003-021-02030-3","article-title":"Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2","volume":"4","year":"2021","journal-title":"Commun Biol"},{"key":"2025090607500459000_2025.09.01.673483v1.18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00560"},{"key":"2025090607500459000_2025.09.01.673483v1.19","doi-asserted-by":"crossref","first-page":"105968","DOI":"10.1016\/j.antiviral.2024.105968","article-title":"A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19","volume":"229","year":"2024","journal-title":"Antiviral Res"},{"issue":"8","key":"2025090607500459000_2025.09.01.673483v1.20","doi-asserted-by":"crossref","first-page":"e0324424","DOI":"10.1128\/spectrum.03244-24","article-title":"Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry","volume":"13","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"3","key":"2025090607500459000_2025.09.01.673483v1.21","doi-asserted-by":"crossref","first-page":"e1009922","DOI":"10.1371\/journal.pcbi.1009922","article-title":"Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants","volume":"18","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"2025090607500459000_2025.09.01.673483v1.22","doi-asserted-by":"crossref","first-page":"110244","DOI":"10.1016\/j.cbi.2022.110244","article-title":"Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation","volume":"368","year":"2022","journal-title":"Chem Biol Interact"},{"key":"2025090607500459000_2025.09.01.673483v1.23","first-page":"100798","article-title":"ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity","volume":"24","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"2025090607500459000_2025.09.01.673483v1.24","doi-asserted-by":"crossref","unstructured":"Strafella C , Caputo V , Termine A , Barati S , Gambardella S , Borgiani P , et al. Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications. Genes (Basel). 2020;11(7).","DOI":"10.3390\/genes11070741"},{"key":"2025090607500459000_2025.09.01.673483v1.25","first-page":"1002187","article-title":"Genetic variations affecting ACE2 protein stability in minority populations","volume":"9","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025090607500459000_2025.09.01.673483v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7000-1_26"},{"issue":"2","key":"2025090607500459000_2025.09.01.673483v1.27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/acs.jctc.7b01099","article-title":"Saturation Mutagenesis by Efficient Free-Energy Calculation","volume":"14","year":"2018","journal-title":"J Chem Theory Comput"},{"key":"2025090607500459000_2025.09.01.673483v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2018.01.002"},{"key":"2025090607500459000_2025.09.01.673483v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.24309"},{"key":"2025090607500459000_2025.09.01.673483v1.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02199-3"},{"key":"2025090607500459000_2025.09.01.673483v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btab806"},{"key":"2025090607500459000_2025.09.01.673483v1.32","doi-asserted-by":"crossref","unstructured":"Rosignoli S , Paiardini A. Boosting the Full Potential of PyMOL with Structural Biology Plugins. Biomolecules. 2022;12(12).","DOI":"10.3390\/biom12121764"},{"issue":"1","key":"2025090607500459000_2025.09.01.673483v1.33","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1080\/22221751.2020.1815589","article-title":"Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells","volume":"9","year":"2020","journal-title":"Emerg Microbes Infect"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.09.01.673483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:05:44Z","timestamp":1782277544000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.09.01.673483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1101\/2025.09.01.673483","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1128\/jvi.01468-25","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,9,2]]},"subtype":"preprint"}}